Neurology
Armadin, solution for injection 50 mg/ml, 2 ml, No. 10
Other forms of release
Link to instruction in PDF format
Registration number :MA No. UA/9896/01/01
Dosage form:Solution for injection
Active substance:ethylmethylhydroxypyridine succinate
Composition :Each ampoule contains 100 mg of 2-ethyl-6-methyl-3-hydroxypyridine succinate; excipient: water for injection.
Therapeutic indications :
- acute cerebrovascular disorders;
- craniocerebral injury, consequences of craniocerebral injuries;
- dyscirculatory encephalopathy;
- neurocirculatory dystonia;
- mild cognitive disorders of atherosclerotic origin;
- anxiety states in neurotic and neurosis-like conditions;
- acute myocardial infarction (from the first day), as part of complex therapy;
- primary open-angle glaucoma of various stages, as part of complex therapy;
- arresting the withdrawal syndrome in alcoholism with a predominance of neurosis-like and neurocirculatory disorders;
- acute intoxication with antipsychotic drugs;
- acute purulent-inflammatory processes in the abdominal cavity (acute necrotic pancreatitis, peritonitis), as part of complex therapy;
Shelf life :5 років
Other in the therapeutic group